Shares of Elevance Health Inc. ELV rallied 1.02% to $396.88 Friday, on what proved to be an all-around favorable trading ...

Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $3.82 per share in its upcoming release, pointing to a year-over-year decline of 32%.

For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.

Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which ...

Elevance Health says its acquisition of Verily’s Granular Insurance is designed to bolster its offerings to self-funded ...

Elevance Health has underperformed the broader market in 2024, down nearly 7% for the year to date. Still, Wall Street remains bullish on the healthcare stock. According to S&P Global Market ...

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a ...

Buying $100 In ELV: If an investor had bought $100 of ELV stock 20 years ago, it would be worth $646.73 today based on a ...

The recent price dip presents an exceptional buying opportunity, with Wall Street also bullish, averaging a price target of $500.87, a 30% upside. I am updating my analysis on Elevance Health ...

The primary driver behind last 12 months revenue was the Health Benefits segment contributing a total revenue of US$150.3b (85% of total revenue). Notably, cost of sales worth US$127.6b amounted to 72 ...

UnitedHealth is under investigation by the Justice Department over its Medicare billing practices and how it records ...